Stockrabit · Analysts
Questions across 1 call

Husain Bharuchwala

Carnelian Capital

Concord Biotech Limited

Concord Biotech Limited CC-Sep24.pdf · 2024-11-12
Sir, just wondering, this will be 2 things. Like one is on the basically on the injectables, we have been delaying the launch of the injectable facility for some time now. So, what is the primary reason that we have been delaying the launch of the injectable facility, if you can explain?
Got it. And second thing, sir, just wanted to understand in the formulation, what is the percentage of the hospital business? Because what we understand is in the hospital business, probably the working capitals is a little elongated so and there are very less margins in the hospital business. So how much percentage of our overall formulation business is towards the hospitals?